Metabolic effects of portal vein sensing

Diabetes, Obesity and Metabolism

Volumn 16, Issue , 2014, Pages 56-60

  Mithieux, G ^a,b  

^a INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Diabetes; Gastrointestinal neural system; Gluconeogenesis; Intestine; Obesity; Portal vein; Protein enriched diet; Soluble fibre

Indexed keywords

ANTIOBESITY AGENT; CYCLIC AMP; FATTY ACID; FREE FATTY ACID RECEPTOR 3; GLUCOSE; GLUCOSE 6 PHOSPHATASE; MELANOCORTIN; METHYLMALONYL COENZYME A MUTASE; MU OPIATE RECEPTOR; PEPTIDE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROPIONIC ACID; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; NERVE PROTEIN; PROTEIN INTAKE; SLC5A4 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER; SUGAR INTAKE;

ANTIDIABETIC ACTIVITY; BRAIN REGION; DIETARY FIBER; ENERGY EXPENDITURE; FOOD INTAKE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE SENSOR; GLUCOSE TOLERANCE; HUMAN; HUNGER; INSULIN SENSITIVITY; METABOLIC DISORDER; METABOLISM; NONHUMAN; PORTAL VEIN; PROTEIN INTAKE; REFLEX ARC; REVIEW; SATIETY; VAGUS NERVE; WEIGHT GAIN; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; FEEDBACK SYSTEM; GLUCOSE BLOOD LEVEL; INNERVATION; INTESTINE MUCOSA; PSYCHOPHYSIOLOGY; SENSORY NERVE CELL; SUGAR INTAKE; UPREGULATION;

ANIMALS; APPETITE REGULATION; BLOOD GLUCOSE; DIETARY FIBER; DIETARY PROTEINS; DIETARY SUCROSE; FEEDBACK, PHYSIOLOGICAL; GLUCONEOGENESIS; HUMANS; INTESTINAL MUCOSA; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURONS, AFFERENT; PORTAL VEIN; SATIETY RESPONSE; SODIUM-GLUCOSE TRANSPORT PROTEINS; UP-REGULATION;

EID: 84908542433     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12338     Document Type: Review

References (37)

1. Little TJ, Feinle-Bisset C. Effects of dietary fat on appetite and energy intake in health and obesity-oral and gastrointestinal sensory contributions. Physiol Behav 2011; 104: 613-620.
2. Janssen P, Van den Berghe P, Verschueren S, Lehmann A, Depoortere I, Tack J. Review article: the role of gastric motility in the control of food intake. Aliment Pharmacol Ther 2011; 33: 880-894.
3. Date Y, Murakami N, Toshinai K et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123: 1120-1128.
4. Smith GP, Jerome C, Cushin BJ, Eterno R, Simansky KJ. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981; 213: 1036-1037.
5. Abbott CR, Monteiro M, Small CJ et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005; 1044: 127-131.
6. Vahl TP, Tauchi M, Durler TS et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007; 148: 4965-4973.
7. Breen D, Yang CS, Lam TK. Gut-brain signaling: how lipids can trigger the gut. Diabetes Metab Res Rev 2011; 27: 113-119.
8. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150: 2518-2525.
9. Sala PC, Torrinhas RS, Heymsfield SB, Waitzberg DL. Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction. Obes Surg 2012; 22: 167-176.
10. Perez-Tilve D, D'Alessio DA, Tschop MH. A sweet spot for the bariatric surgeon. Cell Metab 2008; 8: 177-179.
11. Troy S, Soty M, Ribeiro L et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008; 8: 201-211.
12. Tordoff MG, Friedman MI. Hepatic portal glucose infusions decrease food intake and increase food preference. Am J Physiol 1986; 251: R192-R196.
13. Langhans W, Grossmann F, Geary N. Intrameal hepatic-portal infusion of glucose reduces spontaneous meal size in rats. Physiol Behav 2001; 73: 499-507.
14. Delaere F, Magnan C, Mithieux G. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metab 2010; 36: 257-262.
15. Mithieux G, Misery P, Magnan C et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2005; 2: 321-329.
16. Baird JP, Grill HJ, Kaplan JM. Intake suppression after hepatic portal glucose infusion: all-or-none effect and its temporal threshold. Am J Physiol 1997; 272: R1454-R1460.
17. Delaere F, Duchampt A, Mounien L et al. The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol Metab 2012; 2: 47-53.
18. Freeman S, Bohan D, Darcel N, Raybould HE. Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am J Physiol Gastrointest Liver Physiol 2006; 8: G532-G539.
19. Berthoud HR. Anatomy and function of sensory hepatic nerves. Anat Rec A Discov Moll Cell Evol Biol 2004; 280: 827-835.
20. Pillot B, Duraffourd C, Begeot M et al. Role of hypothalamic melanocortin system in adaptation of food intake to food protein increase in mice. PLoS One 2011; 6: 1-7.
21. Penhoat A, Mutel E, Amigo-Correig M et al. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol Behav 2011; 105: 89-93.
22. Zioudrou C, Streaty RA, Klee WA. Opioid peptides derived from food proteins. The exorphins. J Biol Chem 1979; 254: 2446-2449.
23. Capasso A, Amodeo P, Balboni G et al. Design of mu selective opioid dipeptide antagonists. FEBS Lett 1997; 417: 141-144.
24. Moritoki H, Takei M, Kotani M, Kiso Y, Ishida Y, Endon K. Tripeptides acting on opioid receptors in rat colon. Eur J Pharmacol 1984; 100: 29-39.
25. Schiller P. Opioid dipeptide derivatives with a mixed μ antagonist/δ antagonist, partial μ agonist/δ antagonist or μ agonist/partial δ agonist profile. Am Peptide Symp 2002; 6: 229-270.
26. Lee VH. Membrane transporters. Eur J Pharmacol Sci 2000; Suppl 2: S41-S50.
27. Holzer P. Opioid receptors in the gastrointestinal tract. Regul Pept 2009; 155: 11-17.
28. Duraffourd C, De Vadder F, Goncalves D et al. Mu-opioid receptors and dietary protein stimulate a gut-brain neural circuitry limiting food intake. Cell 2012; 150: 377-388.
29. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012; 9: 577-589.
30. Ray TK, Mansell K, Knight LC, Malmud LS, Owen OE, Boden G. Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients. Am J Clin Nutr 1983; 37: 376-381.
31. Mendeloff AI. Dietary fiber and human health. N Engl J Med 1977; 297: 811-814.
32. Donohoe DR, Garge N, Zhang X et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011; 13: 517-526.
33. Anderson JW, Bridges SR. Short-chain fatty acid fermentation products of plant fiber affect glucose metabolism of isolated rat hepatocytes. Proc Soc Exp Biol Med 1984; 177: 372-376.
34. Clore JN, Stillman J, Sugerman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 2000; 49: 969-974.
35. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 1992; 90: 1323-1327.
36. De Vadder F, Kovatcheva-Datchary P, Goncalves D et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014; 156: 84-96.
37. Gautier-Stein A, Zitoun C, Lalli E, Mithieux G, Rajas F. Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. J Biol Chem 2006; 281: 31268-31278.